Genetics, pathogenesis and complications of osteopetrosis

Bone

Volumn 42, Issue 1, 2008, Pages 19-29

  Del Fattore, Andrea ^a   Cappariello, Alfredo ^a,b   Teti, Anna ^a  

^a Department of Experimental Medicine ^*  (Italy)

^b BAMBINO GESÙ CHILDREN S HOSPITAL   (Italy)

Author keywords

Bone remodeling; Bone resorption; Osteoblast; Osteoclast; Osteopetrosis

Indexed keywords

ALBERS SCHOENBERG DISEASE; AUTOSOMAL RECESSIVE INHERITANCE; BONE MALFORMATION; BONE MARROW; BONE MARROW TRANSPLANTATION; BONE REMODELING; CELL DIFFERENTIATION; CRANIAL NERVE; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE SEVERITY; GENE FUNCTION; GENE MUTATION; GENETICS; HAPLOTYPE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEREDITY; HLA SYSTEM; HUMAN; NERVE DEGENERATION; NONHUMAN; OSTEOBLAST; OSTEOCLAST; OSTEOGENESIS IMPERFECTA; OSTEOLYSIS; OSTEOSCLEROSIS; PATHOGENESIS; REVIEW; SHORT STATURE;

ANIMALS; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MODELS, ANIMAL; MUTATION; OSTEOPETROSIS; SIGNAL TRANSDUCTION;

EID: 37349108189     PISSN: 87563282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bone.2007.08.029     Document Type: Review

References (68)

1. Whyte M.P. Osteopetrosis. In: Royce P.M., and Steinman B. (Eds). Connective tissue and its heritable disorders: medical, genetic, and molecular aspects. Ed2 (2002), Wiley-Liss, Inc, New York 753-770
2. Albers-Schönberg H.E. Röntgenbilder einer seltenen Knockenerkrankung. Munch Med Wochenschr 5 (1904) 365-368
3. Van Wesenbeeck L., and Van Hul W. Lessons from osteopetrotic mutations in animals: impact on our current understanding of osteoclast biology. Crit Rev Eukaryot Gene Expr 15 (2005) 133-162
4. Driessen G.J., Gerritsen E.J., Fischer A., Fasth A., Hop W.C., Veys P., et al. Long-term outcome of haematopoietic stem cell transplantation in autosomal recessive osteopetrosis: an EBMT report. Bone Marrow Transplant 32 (2003) 657-663
5. Walker D.G. The classic: osteopetrosis cured by temporary parabiosis. Clin Orthop Relat Res 162 (1982) 2-3
6. Walker D.G. Bone resorption restored in osteopetrotic mice by transplants of normal bone marrow and spleen cells. Clin Orthop Relat Res 294 (1993) 4-6
7. Gerritsen E.J., Vossen J.M., Fasth A., Friedrich W., Morgan G., Padmos A., et al. Bone marrow transplantation for autosomal recessive osteopetrosis. A report from the Working Party on Inborn Errors of the European Bone Marrow Transplantation Group. J Pediatr 125 (1994) 896-902
8. Teitelbaum S.L., and Ross F.P. Genetic regulation of osteoclast development and function. Nat Rev Genet 4 (2003) 638-649
9. Johansson M., Jansson L., Ehinger M., Fasth A., Karlsson S., and Richter J. Neonatal hematopoietic stem cell transplantation cures oc/oc mice from osteopetrosis. Exp Hematol 34 (2006) 242-249
10. Frattini A., Blair H.C., Sacco M.G., Cerisoli F., Faggioli F., Cto E.M., et al. Rescue of ATPa3-deficient murine malignant osteopetrosis by hematopoietic stem cell transplantation in utero. Proc Natl Acad Sci U S A 102 (2005) 14629-14634
11. Marks Jr. S.C., Seifert M.F., and McGuire J.L. Congenitally osteopetrotic (op/op) mice are not cured by transplants of spleen or bone marrow cells from normal littermates. Metab Bone Dis Relat Res 5 (1984) 183-186
12. Helfrich M.H. Osteoclast diseases. Microsc Res Tech 61 (2003) 514-532
13. Flanagan A.M., Massey H.M., Wilson C., Vellodi A., Horton M.A., and Steward C.G. Macrophage colony-stimulating factor and receptor activator NF-kappaB ligand fail to rescue osteoclast-poor human malignant infantile osteopetrosis in vitro. Bone 30 (2002) 85-90
14. Van Hul W., Vanhoenacker F., Balemans W., Janssens K., and De Schepper A.M. Molecular and radiological diagnosis of sclerosing bone dysplasias. Eur J Radiol 40 (2001) 198-207
15. Kornak U., Kasper D., Bosl M.R., Kaiser E., Schweizer M., Schulz A., et al. Loss of the ClC-7 chloride channel leads to osteopetrosis in mice and man. Cell 104 (2001) 205-215
16. Kasper D., Planells-Cases R., Fuhrmann J.C., Scheel O., Zeitz O., Ruether K., et al. Loss of the chloride channel ClC-7 leads to lysosomal storage disease and neurodegeneration. EMBO J 24 (2005) 1079-1091
17. Lange P.F., Wartosch L., Jentsch T.J., and Fuhrmann J.C. ClC-7 requires Ostm1 as a beta-subunit to support bone resorption and lysosomal function. Nature 440 (2006) 220-223
18. Balemans W., Van Wesenbeeck L., and Van Hul W. A clinical and molecular overview of the human osteopetroses. Calcif Tissue Int 77 (2005) 263-274
19. Bollerslev J., and Andersen Jr. P.E. Radiological, biochemical and hereditary evidence of two types of autosomal dominant osteopetrosis. Bone 9 (1988) 7-13
20. Van Wesenbeeck L., Cleiren E., Gram J., Beals R.K., Benichou O., Scopelliti D., et al. Six novel missense mutations in the LDL receptor-related protein 5 (LRP5) gene in different conditions with an increased bone density. Am J Hum Genet 72 (2003) 763-771
21. Smahi A., Courtois G., Rabia S.H., Doffinger R., Bodemer C., Munnich A., et al. The NF-kappaB signalling pathway in human diseases: from incontinentia pigmenti to ectodermal dysplasias and immune-deficiency syndromes. Hum Mol Genet 11 (2002) 2371-2375 [Review]
22. Yarali N., Fisgin T., Duru F., and Kara A. Osteopetrosis and Glanzmann's thrombasthenia in a child. Ann Hematol 82 (2003) 254-256
23. Kida E., Palminiello S., Golabek A.A., Walus M., Wierzba-Bobrowicz T., Rabe A., et al. Carbonic anhydrase II in the developing and adult human brain. J Neuropathol Exp Neurol 65 (2006) 664-674
24. Monaghan B.A., Kaplan F.S., August C.S., Fallon M.D., and Flannery D.B. Transient infantile osteopetrosis. J Pediatr 118 (1991) 252-256
25. Lerman-Seige T., Levi Y., Kidron D., Grunebaum M., and Nitzan M. Syndrome of osteopetrosis and muscular degeneration associated with cerebro-oculo-facio-skeletal changes. Am J Med Genet 28 (1987) 137-142
26. Ben Hamouda H., Sfar M.N., Braham R., Ben Salah M., Ayadi A., Soua H., et al. Association of severe autosomal recessive osteopetrosis and Dandy-Walker syndrome with agenesis of the corpus callosum. Acta Orthop Belg 67 (2001) 528-532
27. Migliaccio S., Luciani M., Taranta A., De Grossi G., Minisola S., El Hachem M., et al. Association of intermediate osteopetrosis with poikiloderma. J Bone Miner Res 14 (1999) 834-836
28. Krimmel M., Niemann G., Will B., and Reinert S. Surgical correction of craniosynostosis in malignant osteopetrosis. J Craniofac Surg 15 (2004) 218-220
29. Bolt R.J., Wennink J.M., Verbeke J.I., Shah G.N., Sly W.S., and Bokenkamp A. Carbonic anhydrase type II deficiency. Am J Kidney Dis 46 A50 (2005) e71-e73
30. Frattini A., Orchard P.J., Sobacchi C., Giliani S., Abinun M., Mattsson J.P., et al. Defects in TCIRG1 subunit of the vacuolar proton pump are responsible for a subset of human autosomal recessive osteopetrosis. Nat Genet 25 (2000) 343-346
31. +-ATPase cause infantile malignant osteopetrosis. Hum Mol Genet 9 (2000) 2059-2063
32. Cleiren E., Benichou O., Van Hul E., Gram J., Bollerslev J., Singer F.R., et al. Albers-Schonberg disease (autosomal dominant osteopetrosis, type II) results from mutations in the ClCN7 chloride channel gene. Hum Mol Genet 10 (2001) 2861-2867
33. Frattini A., Pangrazio A., Susani L., Sobacchi C., Mirolo M., Abinum M., et al. Chloride channel ClCN7 mutations are responsible for severe recessive, dominant, and intermediate osteopetrosis. J Bone Miner Res 18 (2003) 1740-1747
34. Chalhoub N., Benachenhou N., Rajapurohitam V., Pata M., Ferron M., Frattini A., et al. Grey-lethal mutation induces severe malignant autosomal recessive osteopetrosis in mouse and human. Nat Med 9 (2003) 399-406
35. Van Wesenbeeck L., Odgren P.R., Coxon F.P., Frattini A., Moens P., Perdu B., et al. PLEKHM1 is involved in osteoclastic vesicular transport and mutations in this gene cause osteopetrosis in incisors absent rat and human. J Clin Invest 117 (2007) 919-930
36. Del Fattore A., Van Wesenbeeck L., Fornari R., Peruzzi B., Cappariello A., Rucci N., Spera G., Helfrich M., Van Hul M., Migliaccio S., and Teti A. Focal osteosclerosis in an otherwise osteopenic female patient harbouring a new heterozygote mutation (R714C) of the osteopterosis gene, Pleckstrin Homolog Domain Conyaining Family M (with Run Domain) Member 1 (PLEKHM1). Calcif. Tissue Int. 80 suppl1 (2007) CC002
37. Bothwick K.J., Kandemir N., Topaloglu R., Kornak U., Bakkaloglu A., Yordam N., et al. A phenocopy of CAII deficiency: a novel genetic explanation for inherited infantile osteopetrosis with distal renal tubular acidosis. J Med Genet 40 (2003) 115-121
38. Gelb B.D., Shi G.P., Chapman H.A., and Desnick R.J. Pycnodysostosis, a lysosomal disease caused by cathepsin K deficiency. Science 273 (1996) 1236-1238
39. Del Fattore A., Peruzzi B., Rucci N., Recchia I., Cappariello A., Longo M., et al. Clinical, genetic, and cellular analysis of 49 osteopetrotic patients: implications for diagnosis and treatment. J Med Genet 43 (2006) 315-325
40. Sobacchi C., Frattini A., Guerrini M.M., Abinun M., Pangrazio A., Susani L., et al. Osteoclast-poor human osteopetrosis due to mutations in the gene encoding RANKL. Nat Genet 39 (2007) 960-962
41. Pangrazio A., Poliani P.L., Megarbane A., Lefranc G., Lanino E., Di Rocco M., et al. Mutations in OSTM1 (grey lethal) define a particularly severe form of autosomal recessive osteopetrosis with neural involvement. J Bone Miner Res 21 (2006) 1098-1105
42. Teitelbaum S.L. Osteoclasts: what do they do and how do they do it?. Am J Pathol 170 (2007) 427-435
43. Swazo N.K. Calculating risk/benefit in X-linked severe combined immune deficiency disorder (X-SCID) gene therapy trials: the task of ethical evaluation. J Med Philos 31 (2006) 533-564
44. Waguespack S.G., Koller D.L., White K.E., Fishburn T., Carn G., Buckwalter K.A., et al. Chloride channel 7 (ClCN7) gene mutations and autosomal dominant osteopetrosis, type II. J Bone Miner Res 18 (2003) 1513-1518
45. Benichou O.D., Laredo J.D., and de Vernejoul M.C. Type II autosomal dominant osteopetrosis (Albers-Schonberg disease): clinical and radiological manifestations in 42 patients. Bone 26 (2000) 87-93
46. Brandt S., and Jentsch T.J. ClC-6 and ClC-7 are two novel broadly expressed members of the CLC chloride channel family. FEBS Lett. 377 (1995) 15-20
47. Campos-Xavier A.B., Casanova J.L., Doumaz Y., Feingold J., Munnich A., and Cormier-Daire V. Intrafamilial phenotypic variability of osteopetrosis due to chloride channel 7 (CLCN7) mutations. Am J Med Genet 133 (2005) 216-218
48. Waguespack S.G., Hui S.L., Dimeglio L.A., and Econs M.J. Autosomal dominant osteopetrosis: clinical severity and natural history of 94 subjects with a chloride channel 7 gene mutation. J Clin Endocrinol Metab 92 (2007) 771-778
49. Kornak U., Ostertag A., Branger S., Benichou O., and de Vernejoul M.C. Polymorphisms in the CLCN7 gene modulate bone density in postmenopausal women and in patients with autosomal dominant osteopetrosis type II. J Clin Endocrinol Metab 91 (2006) 995-1000
50. Chu K., Koller D.L., Snyder R., Fishburn T., Lai D., Waguespack S.G., et al. Analysis of variation in expression of autosomal dominant osteopetrosis type 2: searching for modifier genes. Bone 37 (2005) 655-661
51. Pettersson U., Albagha O.M., Mirolo M., Taranta A., Frattini A., McGuigan F.E., et al. Polymorphisms of the CLCN7 gene are associated with BMD in women. J Bone Miner Res 20 (2005) 1960-1967
52. Chu K., Snyder R., and Econs M.J. Disease status in autosomal dominant osteopetrosis type 2 is determined by osteoclastic properties. J Bone Miner Res 21 (2006) 1089-1097
53. Blair H.C., Borysenko C.W., Villa A., Schlesinger P.H., Kalla S.E., Yaroslavskiy B.B., et al. In vitro differentiation of CD14 cells from osteopetrotic subjects: contrasting phenotypes with TCIRG1, CLCN7, and attachment defects. J Bone Miner Res 19 (2004) 1329-1338
54. Henriksen K., Gram J., Schaller S., Dahl B.H., Dziegiel M.H., Bollerslev J., et al. Characterization of osteoclasts from patients harboring a G215R mutation in ClC-7 causing autosomal dominant osteopetrosis type II. Am J Pathol 164 (2004) 1537-1545
55. Teti A., Migliaccio S., Taranta A., Bernardini S., DeRossi G., Lucani M., et al. Mechanisms of osteoclast dysfunction in human osteopetrosis: abnormal osteoclastogenesis and lack of osteoclast-specific adhesion structures. J Bone Miner Res 14 (1999) 2107-2117
56. Karsdal M.A., Martin T.J., Bollerslev J., Christiansen C., and Henriksen K. Are nonresorbing osteoclasts sources of bone anabolic activity?. J Bone Miner Res 22 (2007) 487-494
57. Zhao C., Irie N., Takada Y., Shimoda K., Miyamoto T., Nishiwaki T., Suda T., and Matsuo K. Bidirectional ephrinB2-EphB4 signaling controls bone homeostasis. Cell Metab 4 (2006) 111-121
58. Ryu J., Kim H.J., Chang E.J., Huang H., Banno Y., and Kim H.H. Sphingosine 1-phosphate as a regulator of osteoclast differentiation and osteoclast-osteoblast coupling. EMBO J 25 (2006) 5840-5851
59. Martin T.J., and Sims N.A. Osteoclast-derived activity in the coupling of bone formation to resorption. Trends Mol Med 11 (2005) 76-81
60. Bollerslev J., Mosekilde L., Nielsen H.K., and Mosekilde L. Biomechanical competence of iliac crest trabecular bone in autosomal dominant osteopetrosis type I. Bone 10 (1989) 159-164
61. Alatalo S.L., Ivaska K.K., Waguespack S.G., Econs M.J., Vaananen H.K., and Halleen J.M. Osteoclast-derived serum tartrate-resistant acid phosphatase 5b in Albers-Schonberg disease (type II autosomal dominant osteopetrosis). Clin Chem 50 (2004) 883-890
62. Karsdal M.A., Henriksen K., Sorensen M.G., Gram J., Schaller S., and Dziegiel M.H. Acidification of the osteoclastic resorption compartment provides insight into the coupling of bone formation to bone resorption. Am J Pathol 166 (2005) 467-476
63. Taranta A., Migliaccio S., Recchia I., Caniglia M., Luciani M., De Rossi G., et al. Genotype-phenotype relationship in human ATP6i-dependent autosomal recessive osteopetrosis. Am J Pathol 162 (2003) 57-68
64. Lian J.B., and Marks Jr. S.C. Osteopetrosis in the rat: coexistence of reductions in osteocalcin and bone resorption. Endocrinology 126 (1990) 955-962
65. Lajeunesse D., Busque L., Menard P., Brunette M.G., and Bonny Y. Demonstration of an osteoblast defect in two cases of human malignant osteopetrosis. J Clin Invest 98 (1996) 1835-1842
66. Karsdal M.A., and Henriksen K. Osteoclasts control osteoblast activity. BoneKEy-Osteovision vol. 4 (2007) 19-24
67. Lee S.H., Rho J., Jeong D., Sul J.Y., Kim T., Kim N., et al. v-ATPase V0 subunit d2-deficient mice exhibit impaired osteoclast fusion and increased bone formation. Nat Med 12 (2006) 1403-1409
68. Jansen I., De Vries T., Rasvesloot J., Everts V., and Elferink R.O. Loss of anion exchanger 2 (Ae2) in mice results in osteopetrosis. J Bone Miner Res 21 (2006) 1256 [abstract]